OsteoBiologics
Founded Year
1993Stage
Acquired | AcquiredTotal Raised
$23.8MValuation
$0000Expert Collections containing OsteoBiologics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OsteoBiologics is included in 1 Expert Collection, including Regenerative Medicine.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Latest OsteoBiologics News
Jul 18, 2019
July 18, 2019 06:51 AM Eastern Daylight Time The country research report on United States ortho and osteobiologics market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that are driving and restraining the ortho and osteobiologics market are highlighted in the study. This is an in-depth business intelligence report based on qualitative and quantitative parameters of the market. Additionally, this report provides readers with market insights and detailed analysis of market segments to possible micro levels. The companies and dealers/distributors profiled in the report include manufacturers & suppliers of ortho and osteobiologics market in the United States. The report provides detailed insights into: 1) Demand and supply conditions of ortho and osteobiologics market 2) Factor affecting the ortho and osteobiologics market in the short run and the long run 3) The dynamics including drivers, restraints, opportunities, political, socio-economic factors, and technological factors 4) Key trends and future prospects 5) Leading companies operating in ortho and osteobiologics market and their competitive position in the United States 6) The dealers/distributors profiles provide basic information of top 10 dealers & distributors operating in (United States) ortho and osteobiologics market 7) IGR Matrix: to position the product types 8) Market estimates up to 2024 The report answers questions such as: 1) What is the market size of ortho and osteobiologics market in the United States? 2) What are the factors that affect the growth in ortho and osteobiologics market over the forecast period? 3) What is the competitive position in the United States ortho and osteobiologics market? 4) What are the opportunities in United States ortho and osteobiologics market? 5) What are the modes of entering United States ortho and osteobiologics market? Key Topics Covered
When was OsteoBiologics founded?
OsteoBiologics was founded in 1993.
Where is OsteoBiologics's headquarters?
OsteoBiologics's headquarters is located at 12500 Network Boulevard, San Antonio.
What is OsteoBiologics's latest funding round?
OsteoBiologics's latest funding round is Acquired.
How much did OsteoBiologics raise?
OsteoBiologics raised a total of $23.8M.
Who are the investors of OsteoBiologics?
Investors of OsteoBiologics include Smith & Nephew, Thomas McNerney & Partners, PTV Sciences, The Vertical Group and Woodside Fund.
Who are OsteoBiologics's competitors?
Competitors of OsteoBiologics include ArthroSurface, Diamorph, Expanding Orthopedics, NeoGraft Technologies, LDR Holding and 12 more.
You May Also Like
Biorthex is an orthopedic device manufacturer that develops manufactures and markets innovative spinal interbody fusion devices and instruments for the treatment of degenerative conditions of the human spine
Control Medical Technology designs, develops, and markets medical devices to help physicians, nurses, technicians, and other caregivers improve patient care. Its FDA-approved ASPIRE systems are used to remove fluids, tumors, bone, bone marrow, endometrial fluids, blood clots, tissue, and other pathology, targeting unmet clinical needs in oncology, orthopedics, spine, pain management and cardiovascular medicine.
Gentis is a developer of minimally invasive, biomaterials-based products intended to treat the early-stage degeneration of the spine, which causes back pain. The company's first patented product, DiscCell, is a breakthrough injectable biomaterial that augments or replaces the diseased nucleus pulposus of the spinal disc.
Doctors Research Group focuses on producing and marketing medical products. Currently, they are focusing on the development of a new type of bone cement or bone glue called Kryptonite.
Design, manufacturing and marketing of long term implantable medical devices dedicated to bone reconstruction for applications in orthopedic, spinal, dental and skull-maxillo-facial surgeries.The company's main aim is to conceive bioresorbable implants helping surgeons to improve patients' welfare.
OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.